Janus Henderson Group PLC Olema Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

$207 Billion
Q3 2025

A detailed history of Janus Henderson Group PLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,585,849 shares of OLMA stock, worth $31.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,585,849

Previous 3,022,784 18.63%

Holding current value

$31.2 Million

Previous $12.9 Million 168.72%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$4.38 - $9.65 $2.47 Million - $5.43 Million	563,065 Added 18.63%	3,585,849 $34.6 Million
Q2 2025 Aug 14, 2025	BUY	$3.06 - $5.62 $9.25 Million - $17 Million	3,022,784 New	3,022,784 $12.9 Million
Q3 2024 Nov 14, 2024	SELL	$10.41 - $16.46 $397,662 - $628,772	-38,200 Reduced 68.21%	17,800 $212,000
Q2 2024 Aug 14, 2024	SELL	$8.73 - $13.99 $10.2 Million - $16.3 Million	-1,165,662 Reduced 95.42%	56,000 $605,000
Q1 2024 May 15, 2024	BUY	$10.95 - $16.62 $5.71 Million - $8.67 Million	521,562 Added 74.5%	1,221,662 $13.8 Million
Q4 2023 Feb 14, 2024	BUY	$10.53 - $17.14 $7.37 Million - $12 Million	700,100 New	700,100 $9.82 Million
Q1 2023 May 15, 2023	SELL	$2.55 - $4.97 $2.48 Million - $4.83 Million	-972,127 Reduced 31.8%	2,085,179 $7.24 Million
Q4 2022 Feb 14, 2023	SELL	$2.27 - $3.76 $770,394 - $1.28 Million	-339,381 Reduced 9.99%	3,057,306 $7.49 Million
Q3 2022 Nov 14, 2022	BUY	$2.72 - $5.88 $205,506 - $444,257	75,554 Added 2.27%	3,396,687 $9.37 Million
Q2 2022 Aug 15, 2022	SELL	$2.04 - $4.61 $482,054 - $1.09 Million	-236,301 Reduced 6.64%	3,321,133 $13.5 Million
Q1 2022 May 16, 2022	BUY	$3.89 - $9.43 $2.19 Million - $5.3 Million	561,994 Added 18.76%	3,557,434 $15.1 Million
Q4 2021 Feb 14, 2022	BUY	$8.75 - $30.71 $4.55 Million - $16 Million	519,610 Added 20.99%	2,995,440 $28 Million
Q3 2021 Nov 16, 2021	SELL	$22.96 - $30.13 $17.2 Million - $22.6 Million	-748,848 Reduced 23.22%	2,475,830 $68.2 Million
Q2 2021 Aug 16, 2021	SELL	$21.15 - $36.14 $7.42 Million - $12.7 Million	-350,890 Reduced 9.81%	3,224,678 $90.3 Million
Q1 2021 May 17, 2021	SELL	$27.81 - $53.64 $1.76 Million - $3.39 Million	-63,270 Reduced 1.74%	3,575,568 $114 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $54.5 $135 Million - $198 Million	3,638,838 New	3,638,838 $161 Million

Others Institutions Holding OLMA

# of Institutions

134

Shares Held

65.9M

Call Options Held

379K

Put Options Held

13K

View Full List

About Olema Pharmaceuticals, Inc.

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $351M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

More about OLMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Olema Pharmaceuticals, Inc. Transaction History